Search

Your search keyword '"Calatroni M."' showing total 87 results

Search Constraints

Start Over You searched for: Author "Calatroni M." Remove constraint Author: "Calatroni M."
87 results on '"Calatroni M."'

Search Results

1. Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis

2. Renal involvement in eosinophilic granulomatosis with polyangiitis

6. Goodpasture syndrome and anti-glomerular basement membrane disease

7. The Role of Rituximab in Primary Focal Segmental Glomerulosclerosis of the Adult

8. Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis

9. Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: A case-control study in male population from two COVID-19 regional centers of Lombardy, Italy

10. Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood

11. Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome

12. FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study

13. MYOSTATIN: A NEW PLAYER IN THE COMPLEXITY OF UREMIC VASCULOPATHY

18. ANCA-associated vasculitis in childhood: Recent advances

23. Pathophysiology and clinical studies in CKD 5D

24. Influence of bunch exposure on anthocyanins extractability from grapes skins (Vitis vinifera L.)

28. The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult

29. Goodpasture syndrome and anti-glomerular basement membrane disease

30. Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis

31. Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood

32. Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome

33. ANCA-associated vasculitis in childhood: recent advances

35. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children.

36. Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy.

37. Understanding fluid dynamics and renal perfusion in acute kidney injury management.

38. Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons.

39. Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review.

40. The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome.

41. Immunohistochemical Evaluation of Renal Biopsy with Anti-PD1 and p53 to Solve the Dilemma between Platinum- and Pembrolizumab-Induced AKI: Case Report and Review.

42. Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration.

43. Corrigendum to "Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis" [ Kidney International Reports Volume 9, Issue 4, April 2024, Pages 1047-1056].

45. Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis.

46. Is per-protocol kidney biopsy required in lupus nephritis?

47. Hospital Malnutrition in the Medicine and Neurology Departments: A Complex Challenge.

48. Using Renal Elastography to Predict the Therapeutic Response of Nephrological Patients.

49. C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis.

50. Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years.

Catalog

Books, media, physical & digital resources